These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18282258)

  • 41. Effects of the anticholinesterase edrophonium on spectral analysis of heart rate and blood pressure variability in humans.
    Deschamps A; Backman SB; Novak V; Plourde G; Fiset P; Chartrand D
    J Pharmacol Exp Ther; 2002 Jan; 300(1):112-7. PubMed ID: 11752105
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of two pre-anaesthetic medetomidine doses in isoflurane anaesthetized sheep.
    Kästner SB; Kutter AP; von Rechenberg B; Bettschart-Wolfensberger R
    Vet Anaesth Analg; 2006 Jan; 33(1):8-16. PubMed ID: 16412127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuromuscular and cardiovascular effects of atracurium in isoflurane-anesthetized chickens.
    Nicholson A; Ilkiw JE
    Am J Vet Res; 1992 Dec; 53(12):2337-42. PubMed ID: 1476319
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of gentamicin administration on the neuromuscular blockade induced by atracurium in cats.
    Forsyth SF; Ilkiw JE; Hildebrand SV
    Am J Vet Res; 1990 Oct; 51(10):1675-8. PubMed ID: 2240789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antagonism of neuromuscular blockade. The cardiovascular effects in children of the combination of edrophonium and glycopyrronium.
    Goldhill DR; Pyne A; Jones CJ
    Anaesthesia; 1988 Nov; 43(11):930-4. PubMed ID: 3213918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of cis-atracurium to maintain moderate neuromuscular blockade in experimental pigs.
    Tutunaru A; Dupont J; Huberty V; Ibrahim M; Serteyn D; Sandersen C
    Vet Anaesth Analg; 2017 Jul; 44(4):910-914. PubMed ID: 28739108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Edrophonium-hyoscine butylbromide mixture for reversal of neuromuscular blockade: heart rate changes in infants and children.
    Yamashita M; Tajima K
    Anaesthesia; 1988 Jul; 43(7):591-3. PubMed ID: 3414927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Twitch potentiation: a potential source of error during neuromuscular monitoring with acceleromyography in anesthetized dogs.
    Martin-Flores M; Lau EJ; Campoy L; Erb HN; Gleed RD
    Vet Anaesth Analg; 2011 Jul; 38(4):328-35. PubMed ID: 21627757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical use of the neuromuscular blocking agents atracurium and pancuronium for equine anesthesia.
    Hildebrand SV; Holland M; Copland VS; Daunt D; Brock N
    J Am Vet Med Assoc; 1989 Jul; 195(2):212-9. PubMed ID: 2768037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of age, isoflurane and sevoflurane on atracurium in lambs.
    Schöffmann G; Vettorato E; Burke JG; Gibson AJ; Clutton ER
    Vet Anaesth Analg; 2012 May; 39(3):256-65. PubMed ID: 22420325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The heart rate following edrophonium-atropine and edrophonium-glycopyrrolate mixtures.
    Azar I; Pham AN; Karambelkar DJ; Lear E
    Anesthesiology; 1983 Aug; 59(2):139-41. PubMed ID: 6869871
    [No Abstract]   [Full Text] [Related]  

  • 53. The Safety of Neuromuscular Blockade Reversal in Patients With Cardiac Transplantation.
    Barbara DW; Christensen JM; Mauermann WJ; Dearani JA; Hyder JA
    Transplantation; 2016 Dec; 100(12):2723-2728. PubMed ID: 26760570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A simulation of neuromuscular function and heart rate during induction, maintenance, and reversal of neuromuscular blockade.
    Jaklitsch RR; Westenskow DR
    J Clin Monit; 1990 Jan; 6(1):24-38. PubMed ID: 2404085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Administration of atropine and onset of neuromuscular block produced by atracurium in infants.
    Simhi E; Brandom BW; Lloyd ME; Woelfel SK
    Paediatr Anaesth; 1997; 7(5):375-8. PubMed ID: 9308060
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atracurium recovery: prediction of safe reversal times with edrophonium.
    Cashman JN; Jones RM; Adams AP
    Anaesthesia; 1989 Oct; 44(10):805-7. PubMed ID: 2589604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of penehyclidine hydrochloride or atropine combined with neostigmine for antagonizing residual neuromuscular block on patient's hemodynamics].
    Liang SW; Chen YM
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1581-2. PubMed ID: 16361173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A preliminary assessment of atracurium, a new competitive neuromuscular blocking agent.
    Coker GG; Dewar GH; Hughes R; Hunt TM; Payne JP; Stenlake JB; Waigh RD
    Acta Anaesthesiol Scand; 1981 Feb; 25(1):67-9. PubMed ID: 7293706
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The parasympathetic nervous system and the thermic effect of glucose/insulin infusions in humans.
    Dériaz O; Nacht CA; Chioléro R; Jéquier E; Acheson KJ
    Metabolism; 1989 Nov; 38(11):1082-8. PubMed ID: 2682136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal of neuromuscular blockade.
    Bevan DR; Donati F; Kopman AF
    Anesthesiology; 1992 Oct; 77(4):785-805. PubMed ID: 1416176
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.